secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2023-08-28T23:59:59+00:00
Accession:  0001213900-23-071247
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Water Biotech receives Nasdaq deficiency notice for late Q2 2023 10-Q filing
--------------------------------------------------------------------------------

- Received Nasdaq deficiency notice on August 22, 2023 for failing to timely file Form 10-Q for quarter ended June 30, 2023.
- Has 60 calendar days to submit a compliance plan; Nasdaq may grant extension until February 20, 2024.
- Company cites ongoing review of employee expenditures as reason for delay; no timeline for filing given.
- Notice does not immediately affect listing or trading of BWV common stock on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023071247/0001213900-23-071247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023071247/ea184317-8k_bluewater.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-071247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer